Search:

Home Index Back issues Contact

 

Volume 6, Number 3

 

Organised inpatient care for acute stroke

James Kelly BSc MRCP Research Fellow, Anthony Rudd FRCP Consultant Physician and Lead Clinician for Stroke St Thomas’ Hospital, London

Despite being the third most common cause of death and the most frequent cause of severe disability in the developed world,1 there have been relatively few advances in acute management of stroke in recent years, unlike in acute myocardial infarction (Box 1 on page 3).

 

Comment: What do readers want?

Peter Rose, Editor

Thrombus is now in its sixth year and at the recent Editorial Board meeting the future focus of the publication was discussed. Currently, the circulation is to haematologists, chest physicians, cardiologists and practices in primary care known to have an interest in anticoagulant management. The circulation also includes members of the Clinical Leaders of Thrombosis (CLOT), with its large membership of anticoagulant/DVT nurse specialists and pharmacists.

 

Managing retinal vein thrombosis: a visionary approach

Denise O’Shaughnessy DPhil MBA FRCP FRCPath Consultant Haematologist; Iain Chisholm MB Camb. BChir MA Camb. FRCS Eng. FRCOphth DO Eng. Consultant Ophthalmologist, Southampton University Hospitals Trust

Retinal vein occlusion (RVO) is a relatively common retinal vascular disorder that is second only to diabetic retinopathy as a cause of visual loss. There are two forms – branch occlusion and central vein occlusion (CVO) – and these differ in many respects.

 

The management of thrombocytopenia in pregnancy

Adrian Copplestone FRCP FRCPath Consultant Haematologist, Derriford Hospital, Plymouth

Maternal thrombocytopenia is not uncommon during pregnancy. The benign nature of gestational thrombocytopenia has now been recognised, but this means there is a risk that the more serious causes of thrombocytopenia are overlooked. This article addresses the practical management of maternal thrombocytopenia. It does not address the question of fetal or neonatal thrombocytopenia. (In neonatal alloimmune thrombocytopenia, the maternal platelet count is normal.)

 

Talking to your patients about thrombophilia

Caroline Baglin RGN Thrombophilia Nurse Specialist, Addenbrooke’s NHS Trust, Cambridge

This article is designed to help you explain the basics of thrombophilia and thrombophilia testing to your patients.

 

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk